As of Feb 10
| -0.28 / -1.49%|
The 8 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 51.00, with a high estimate of 56.00 and a low estimate of 44.00. The median estimate represents a +175.97% increase from the last price of 18.48.
The current consensus among 8 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.